Niridazole biodegradable inserts for local long-term treatment of periodontitis: Possible new life for an orphan drug

Drug Delivery

Volumn 13, Issue 5, 2006, Pages 365-373

  Barat, Romi ^a   Srinatha, A ^b   Pandit, J ^b,f   Ridhurkar, D ^b   Balasubramaniam, J ^c   Mittal, Neelam ^d   Mishra, Deena ^e  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c ISP Hong Kong Limited   (India)

^d BANARAS HINDU UNIVERSITY   (India)

^e GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^f BANARAS HINDU UNIVERSITY   (India)

Author keywords

Biodegradable; Niridazole; Periodontitis; Resomer ; RG 503H; RG858

Indexed keywords

NIRIDAZOLE; RESOMER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FEMALE; HUMAN; IN VITRO STUDY; LONG TERM CARE; MALE; PERIODONTITIS; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

ABSORBABLE IMPLANTS; ADOLESCENT; ADULT; DRUG CARRIERS; GINGIVAL HEMORRHAGE; HUMANS; MIDDLE AGED; NIRIDAZOLE; ORPHAN DRUG PRODUCTION; PERIODONTAL INDEX; PERIODONTITIS; PILOT PROJECTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33746814469     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500398126     Document Type: Article

References (36)

1. Andraus, P., Thomas, M., and Szubert, P. R. 1983. Praziquantel. Med. Res. Rev. 3:147-200.
2. Arrona, G., DeRosa, A., Rosso, F., et al. 1998. A biocompatibility study of the effects of slow-release antibiotic materials in the treatment of periodontal disease-I. The biocompatibility of cellulose acetate charged with 25% tetracycline hydrochloride. A clinical and scanning microscopic study of a case. Minerva Stomatol. 47:553-557.
3. Becker, W., Berg, L., and Becker, B. E. 1979. Untreated periodontal disease: a longitudinal study. J. Periodontol. 50:234-244.
4. Bharadwaj, R., and Blanchard, J. 2001. In vitro evaluation of poly (D, L- lactide-co-glycolate) polymer based implants containing the α-melanocyte stimulating hormone analog melatonin-I. J. Control. Rel. 45:49-55.
5. Bottenberg, P., Cleymaet, R., DeMuyncle, C., et al. 1992. Comparison of salivary fluoride concentrations after administration of a bioadhesive slow release tablet and a conventional fluoride tablet. J. Pharm. Pharmacol. 44:684-686.
6. Britt, M. R., and Pohlod, D. J. 1986. Serum and crevicular fluid concentrations after a single oral dose of metronidazole. J. Periodontol. 57:104-107.
7. Buckely, L. A., and Crowley, M. J. 1984. A longitudinal study of untreated periodontal disease. J. Clin. Periodontol. 11:523-530.
8. Ciancio, S. G. 1999. Local delivery of chlorhexidine. Compend. Contin. Edu. Dent. 20:427-432.
9. Fukuzaki, H., Yoshida, M., Asano, M., et al. 1991. In vivo characterists of high, molecular weight co-poly(L-lactide/glycolide) with S-type degradation pattern for application in drug delivery systems. Biomaterials 12:433-437.
10. Furr, B. J. A., and Hutchison, F. G. 1991. A biodegradable delivery system for perptides: preclinical experience with the gonadotrophin releasing hormone agonist zoladex. J. Control. Rel. 21:117-127.
11. Garret, S., Johnson, L., Drisko, S. H., et al. 1999. Two multicenter studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene and scaling and root planing in treatment of periodontitis. J. Peridontol. 70:490-503.
12. Gordon, J. M., Walker, C. B., Murphy, J. C., et al. 1981. Tetracyclines: levels achievable in gingival crevice fluid and In vitro effect in subgingival organism, Part-I: concentrations in crevicular fluid after repeated dose. J. Periodontol. 52:609-612.
13. Grizzi, I., Garreau, H., Li, S., and Vert, M. 1995. Hydrolytic degradation of devices based on poly(D L- lactic acid) size dependence. Biomaterials 16:305-311.
14. Guinchedi, P., Conti, B., Scalia, S., et al. 1994. Proceedings. Int. Sym. Contr. Rel. Bioact. Mat. 24: 997.
15. Hellden, L. B., Listergarten, M. A., and Lindhe, J. J. 1979. The effects of tetracycline and/or scaling on human periodontal disease. J. Clin. Periodontol. 6:222-230.
16. Higashi, K., Seike, M., Mitani, Y., et al. 1989. Concentration of ofloxacin in human gingival crevicular fluid after oral administration of Trivid. J. Periodont. Res. 24: 409-411.
17. Hof, H., and Sticht-Groh. V. 1984, Antibacterial effects of niridazole: its effect on microaerophilic campylobacter. Infection 12:36-39.
18. Hof, H., and Stroder, J. 1986. Antibacterial activity of GO 10213, a nitroimidazole derivative. Antimicrob. Agents Chemother. 29:953-954.
19. Hof, H., Eisenbarth, B., Denzler, A., et al. 1985. Therapeutic activities of nitrothiazole derivatives in experimental infections with salmonella typhimurium and bacterioids fragilis. J. Antimicrob. Chemother. 16:205-210.
20. Joyston-Bedral, S. 1987. Topical and systemic antimicrobial agents in the treatment of chronic gingivitis and periodontitis. Int. Dent. J. 31:52-62.
21. Kinnane, D. F., and Radvan, M. 1999. A six-month comparison of three periodontal local anti-microbial therapies in persistent periodontal pockets. J. Periodontol. 70:1-7.
22. Lewis, D. H. 1990. Controlled release of bioactive agents from lactide/glycolide polymers. In: Biodegradable Polymers as Drug Delivery Systems, eds. Chasin, M and Langer, R. New York: Marcel Dekker.
23. Lindhe, J., and Nyman, S. 1984. Long-term maintenance of patients treated for advanced periodontal disease. J. Clin. Periodontol. 11:504-514.
24. Lindhe, J., Haffajee, A. J., and Socransky, S. S. 1983. Progression of periodontal disease in adult subjects in the absence of periodontal therapy. J. Clin. Periodontol. 10:433-442.
25. Mahmoud, A. A. 1977. Current concepts: schistosomiasis. N. Engl. J. Med. 297:1329-1331.
26. Medlicott, N. J., Tucker, I. G., and Holborow, D. W. 1994. Delivery systems for the administration of drugs to the periodontal pocket. Adv. Drug Del. Rev. 13:181-203.
27. Ramfjord, S. P. 1987. Maintenance case for treated periodontitis patients. J. Clin. Periodontol. 14:433-437.
28. Reed, A. M., and Gilding, D. K. 1981. Biodegradable polymers for use in surgery - poly (glycolic)/ poly (lactic acid) homo and copolymers: 2. In vitro degradation. Polymer 22:491-496.
29. Sanders, L. M., Kent, J. S., McRae, G. I., et al. 1994. Controlled release of luteinizing hormone-releasing hormone analogue from poly (D, L-lacitde-co-glycolide) microspheres. J. Pharm. Sci. 73:1294-1297.
30. Slots, J., and Rams, T. E. 1990. Antibiotics in periodontal therapy: advantages and disadvantages. J. Clin. Periodontol. 17:479-493.
31. Somayaji, B. V., Jariwala, U., Jayachandran, P., et al. 1998. Evaluation of antimicrobial efficacy and release pattern of tetracycline and metronidazole using a local delivery. J. Periodontol. 69:409-413.
32. Valencia, C. I., Catto, B. A., Fairchild, E. H., et al. 1984. Concentration time course of niridazole and six metabolites in the serum of four Filipinos with schisotosome japonicum. J. Pharm. Exp. Ther. 230:133-140.
33. Van Oosten, M. A. C., Notten, F. J. W., and Mike, F. H. M. 1986. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose. Dent. Res. 65:1420-1423.
34. Vander-Oudera, F. J. G. 1991. Anti-plaque agents. Rationale and prospects for prevention of gingivitis and periodontal disease. J. Clin. Periodontol. 18:447-554.
35. Vishwanathan, N. B., Patil, S. S., Pandit, J. K., et al. 2001. Morphological changes in degrading PLGA and P(DL)LA microspheres: implications for the design of controlled release systems. J. Microencap. 18:783-800.
36. Wade, W. G., and Addy, M. 1987, Comparison of in vitro activity of niridazole, metronidazole and tetracycline against subgingival bacteria in chronic periodontitis. J. Appl. Bacteriol. 63:455-457.